Alyssa J. Cozzo

University of North Carolina at Chapel Hill

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer”.

cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer

UNC Libraries(2020)10.17615/665e-3747

N/A

0DataRank · unranked

0 citations

Melissa A. Troester, Alex J. Freemerman, Stephanie A. Montgomery, Luma Essaid, Kirk K. McNaughton +8 more

Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2020)10.17615/vyqs-0e71

N/A

0DataRank · unranked

0 citations

Amy Johnson, Brittney Dietz, Yuanyuan Qin, Melinda A. Beck, Ying Wu +16 more

An optimized fractionation method reveals insulin-induced membrane surface localization of GLUT1 to increase glycolysis in LβT2 cells

Molecular and Cellular Endocrinology(2024)10.1016/j.mce.2024.112405

N/A

0DataRank · unranked

0 citations

Kiara Dominique Wiggins, Anjali Varma, Zena Del Mundo, José Antonio Adame, Alyssa J. Cozzo +12 more

The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression

Breast Cancer Research(2025)10.1186/s13058-025-02134-2

N/A

0DataRank · unranked

0 citations

Shannon B. McDonell, Lydia K. Eisenbeis, Emily N. Devericks, Jobin Chandi, Om Dave +16 more